PACIFIC BIOSCIENCES OF CALIFORNIA news, videos and press releases
For more news please use our advanced search feature.
PACIFIC BIOSCIENCES OF CALIFORNIA - More news...
PACIFIC BIOSCIENCES OF CALIFORNIA - More news...
- PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
- PacBio Announces First Quarter 2024 Financial Results
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
- Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
- PacBio Grants Equity Incentive Award to New Employee
- PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
- PacBio to Present at Upcoming Investor Conferences
- PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results
- PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale
- PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024
- PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions
- PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively
- PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference
- PacBio Announces the Retirement of David Botstein, Ph.D., from its Board of Directors
- PacBio to Present at Upcoming Investor Conferences
- PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders
- PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible
- PacBio Announces Kinnex RNA Kits, Further Scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA Applications
- PacBio Announces Third Quarter 2023 Financial Results
- PacBio Announces Appointment of David Meline to Board of Directors
- PacBio to Report Third Quarter 2023 Financial Results on October 30, 2023
- PacBio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis
- PacBio Announces PacBio Capital
- PacBio Announces Collaboration with Leading Library Preparation Automation Partners
- PacBio to Present at Upcoming Investor Conferences
- PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care
- PacBio Reports Equity Incentive Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4)
- PacBio Announces Second Quarter 2023 Financial Results
- PacBio Enters into Agreement to Acquire Apton Biosystems to Accelerate the Development of a Next Generation, High Throughput, Short-read Sequencer
